Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Resources / Miscellaneous Resources

Miscellaneous Resources

Various other resources.

Contents

Knowledge Object HGNC entry for human FABP5
Knowledge Object HGNC entry for human FAM83H
Knowledge Object HGNC entry for human FAS
Knowledge Object HGNC entry for human FAS
Knowledge Object HGNC entry for human FGF2
Knowledge Object HGNC entry for human FGF17
Knowledge Object HGNC entry for human FHIT
Knowledge Object HGNC entry for human FIGF
Knowledge Object HGNC entry for human FJX1
Knowledge Object HGNC entry for human FLT1
Knowledge Object HGNC entry for human FLT3LG
Knowledge Object HGNC entry for human FMO5
Knowledge Object HGNC entry for human FNDC3A
Knowledge Object HGNC entry for human FOLH1B
Knowledge Object HGNC entry for human follicle stimulating hormone, beta polypeptide
Knowledge Object HGNC entry for human FOLR1
Knowledge Object HGNC entry for human FRS3
Knowledge Object HGNC entry for human FYN
Knowledge Object HGNC entry for human FZD10
Knowledge Object HGNC entry for human GADD45B
Knowledge Object HGNC entry for human GAGE7
Knowledge Object HGNC entry for human GATA4
Knowledge Object HGNC entry for human GCLM
Knowledge Object HGNC entry for human GDF15, also known as MIC1
Knowledge Object HGNC entry for human GDNF
Knowledge Object HGNC entry for human GH1, growth hormone
Knowledge Object HGNC entry for human GLO1
Knowledge Object HGNC entry for human GNB4
Knowledge Object HGNC entry for human GOLM1, also known as GP73
Knowledge Object HGNC entry for human GPI
Knowledge Object HGNC entry for human GPKOW
Knowledge Object HGNC entry for human GPKOW
Knowledge Object HGNC entry for human GPM6B
Knowledge Object HGNC entry for human GPR65
Knowledge Object HGNC entry for human GPR157
Knowledge Object HGNC entry for human GPX1
Knowledge Object HGNC entry for human GPX3
Knowledge Object HGNC entry for human GSTM1
Knowledge Object HGNC entry for human GSTM2
Knowledge Object HGNC entry for human GSTM3
Knowledge Object HGNC entry for human GSTP1
Knowledge Object HGNC entry for human GSTT1
Knowledge Object HGNC entry for human GSTZ1
Knowledge Object HGNC entry for human heat shock protein 90 alpha, HSP90AA1
Knowledge Object HGNC entry for human hepcidin antimicrobial peptide HAMP
Knowledge Object HGNC entry for human HGF
Knowledge Object HGNC entry for human HIST1H2BC
Knowledge Object HGNC entry for human HIST1H2BE
Knowledge Object HGNC entry for human HIST1H2BF
Knowledge Object HGNC entry for human HIST1H2BI
Knowledge Object HGNC entry for human HOXA9
Knowledge Object HGNC entry for human HOXD1
Knowledge Object HGNC entry for human HSD17B10
Knowledge Object HGNC entry for human HSP90AB1
Knowledge Object HGNC entry for human HSPA9
Knowledge Object HGNC entry for human HSPB8
Knowledge Object HGNC entry for human HYAL2
Knowledge Object HGNC entry for human ICAM1
Knowledge Object HGNC entry for human IFNG
Knowledge Object HGNC entry for human IL1B
Knowledge Object HGNC entry for human IL2
Knowledge Object HGNC entry for human IL4
Knowledge Object HGNC entry for human IL5
Knowledge Object HGNC entry for human IL12A
Knowledge Object HGNC entry for human IL12B
Knowledge Object HGNC entry for human IL13
Knowledge Object HGNC entry for human IL15RA
Knowledge Object HGNC entry for human IL17B
Knowledge Object HGNC entry for human IL18
Knowledge Object HGNC entry for human IMPDH2
Knowledge Object HGNC entry for human insulin-like growth factor 2 (somatomedin A) IGF2
Knowledge Object HGNC entry for human insulin-like growth factor binding protein 1 IGFBP1
Knowledge Object HGNC entry for human insulin-like growth factor binding protein 2 IGFBP2
Knowledge Object HGNC entry for human inter-alpha-trypsin inhibitor heavy chain family, member 4 ITIH4
Knowledge Object HGNC entry for human interleukin 6 (interferon, beta 2) IL6
Knowledge Object HGNC entry for human interleukin 8 IL8
Knowledge Object HGNC entry for human interleukin 10 IL10
Knowledge Object HGNC entry for human ITGB1
Knowledge Object HGNC entry for human ITGBL1
Knowledge Object HGNC entry for human JUNB
Knowledge Object HGNC entry for human KDR
Knowledge Object HGNC entry for human keratin 19 KRT19
Knowledge Object HGNC entry for human KIF1A
Knowledge Object HGNC entry for human KLK3
Knowledge Object HGNC entry for human KLK7
Knowledge Object HGNC entry for human KLK8
Knowledge Object HGNC entry for human KPNB1
Knowledge Object HGNC entry for human LBP
Knowledge Object HGNC entry for human LCP2
Knowledge Object HGNC entry for human LDHB
Knowledge Object HGNC entry for human LGALS3BP
Knowledge Object HGNC entry for human LGMN
Knowledge Object HGNC entry for human LHB
Knowledge Object HGNC entry for human LPAR3
Knowledge Object HGNC entry for human LRIG3
Knowledge Object HGNC entry for human LTBP2
Knowledge Object HGNC entry for human LZTS1
Knowledge Object HGNC entry for human MAGEA4
Knowledge Object HGNC entry for human MAGEA6
Knowledge Object HGNC entry for human MALAT1
New Funding Opportunity: Biomarker Development Laboratories for the Early Detection Network: Applications Due May 23

Update: Pre-application webinar information now available.

The National Cancer Institute's Division of Cancer Prevention has released a new funding opportunity to solicit organ-specific applications for Biomarker Developmental Laboratories (BDLs), one of the four scientific units of the recently funded Early Detection Research Network (EDRN). The EDRN is a national infrastructure funded to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. BDLs are responsible for the discovery, development, characterization, and testing of new, or the refinement of existing, biomarkers and biomarker assays for risk assessment, detection, and molecular diagnosis and prognosis of cancers.

The existing BDLs are primarily focused on ovary and gastrointestinal cancers. The proposed BDLs (to be supported under this funding opportunity) should be focused on one or more of the following cancers: breast, prostate and other genitourinary organs, or lung. In addition, cancers with rapidly rising incidence rates, e.g., endometrial, hepatocellular, kidney, thyroid, oropharyngeal cancers, and/or cancers with unique etiology, e.g., mesothelioma, will be considered.

The newly funded units of the Early Detection Research Network will be announced later in April. Successful applicants have already been notified. Those researchers who were not successful during the last round of applications are encouraged to apply to this opportunity.